Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
301
datasets available to search
ShareScore release 0.9.0
Dataset results
301 results for “sitagliptin”
Effects of Sitagliptin on Postprandial Lipemia in Men With Type 2 Diabetes
ClinicalTrials.gov study NCT00660075. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass
ClinicalTrials.gov study NCT00775684. IPD Sharing: NO. Countries: 1. Publications: 7.
Effectiveness of Sitagliptin for HIV Insulin Resistance and Inflammation
ClinicalTrials.gov study NCT01552694. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sitagliptin in Combination With Metformin and Sulfonylurea
ClinicalTrials.gov study NCT00686634. IPD Sharing: Not stated. Countries: 1. Publications: 1.
The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus
ClinicalTrials.gov study NCT01092663. IPD Sharing: Not stated. Countries: 1. Publications: 7.
Impact of Sitagliptin on Cardiovascular Exercise Performance in Type 2 Diabetes
ClinicalTrials.gov study NCT01951339. IPD Sharing: NO. Countries: 1. Publications: 1.
The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes
ClinicalTrials.gov study NCT02008682. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Mechanisms of Glucose Lowering Effects of Sitagliptin and Metformin Alone and in Combination in Patients With T2DM
ClinicalTrials.gov study NCT00820573. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Comparative Efficacy and Safety of Sitagliptin Phosphate Combined with Gliclazide Sustained-Release Tablets Versus Metformin in Treatment-Naïve Patients with Type 2 Diabetes Mellitus and Glucotoxicity: A Single-Center, Prospective, Randomized Controlled Non-Inferiority Study
<p>This dataset supports the manuscript titled "Comparative Efficacy and Safety of Sitagliptin Phosphate Combined with Gliclazide Sustained-Release Tablets Versus Metformin in Treatment-Naïve Patients with Type 2 Diabetes Mellitus and Glucotoxicity: A Single-Center, Prospective, Randomized Controlled Non-Inferiority Study." The study aims to compare the efficacy and safety of sitagliptin phosphate combined with gliclazide sustained-release tablets against metformin in treatment-naïve patients with type 2 diabetes mellitus and glucotoxicity. Data include clinical measurements, laboratory test results, and adverse event records collected throughout the trial period. Statistical analyses were conducted to assess non-inferiority between the two treatment groups. This dataset provides valuable insights for researchers interested in diabetes management, pharmacotherapy, and randomized controlled trials.</p>
Association between a glucagon-like peptide 1 receptor genetic polymorphism and therapeutic response to sitagliptin in a sample of type 2 diabetic patients: an observational study
<p>Association between a glucagon-like peptide 1 receptor genetic polymorphism and therapeutic response to sitagliptin in a sample of type 2 diabetic patients: an observational study</p>
Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes
ClinicalTrials.gov study NCT06759922. IPD Sharing: YES. Countries: 1. Publications: 14.
A Study of the Safety and Efficacy of Glimepiride, Gliclazide, Repaglinide or Acarbose When Added to Sitagliptin + Metformin Combination Therapy in Chinese Participants With Diabetes (MK-0431-313)
ClinicalTrials.gov study NCT01709305. IPD Sharing: YES. Countries: 0. Publications: 1.
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
ClinicalTrials.gov study NCT00704132. IPD Sharing: YES. Countries: 0. Publications: 1.
Effect of Lixisenatide on Postprandial Plasma Glucose Compared to Sitagliptin in Combination With Insulin Glargine
ClinicalTrials.gov study NCT02200991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Randomized Evaluation of Anagliptin Versus Sitagliptin On Low-density lipoproteiN Cholesterol in Diabetes Trial
ClinicalTrials.gov study NCT02330406. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
A Study of Sitagliptin in Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Diet/Exercise Therapy (0431-054)(COMPLETED)
ClinicalTrials.gov study NCT00411554. IPD Sharing: Not stated. Countries: 0. Publications: 1.
MK0431 (Sitagliptin) and Metformin Co-Administration Factorial Study in Patients With Type 2 Diabetes Mellitus (0431-036)
ClinicalTrials.gov study NCT00103857. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
ClinicalTrials.gov study NCT00616811. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study
ClinicalTrials.gov study NCT05556291. IPD Sharing: NO. Countries: 1. Publications: 12.
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
ClinicalTrials.gov study NCT03208465. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.